TRACER PHARMA ApS: Financial statements 2024
CVR: 34090106
Source: annual report 2024, Danish Business Authority
01/05/2023 – 30/04/2024
TRACER PHARMA ApS (CVR 34090106) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 5,412,899 and a net result of DKK 1,705,344 compared with DKK 96,954 the year before. That is an increase of 32.8% compared with the year before. Equity in the 2024 report amounted to DKK 2,079,303. The solvency ratio was 44.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 5,412,899
- Profit/Loss
- DKK 1,705,344
- Equity
- DKK 2,079,303
- Total Assets
- DKK 4,662,012
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 5.4 mio. | 1.7 mio. | 2.1 mio. | 3 |
| 2023 | - | 4.1 mio. | 97 t. | 1.4 mio. | 5 |
| 2022 | - | 3.9 mio. | 145 t. | 1.6 mio. | 5 |
| 2021 | - | 4 mio. | 832 t. | 1.5 mio. | 5 |
| 2020 | - | 4.4 mio. | 455 t. | 650 t. | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout TRACER PHARMA ApS
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011. The company has been dissolved on 28 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity in the 2025 report amounted to DKK 867,174.